LDLi-Min Deng

Li-Min Deng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Li-Min Deng has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hui-Ying Yue

    National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, South China Agricultural University, Guangzhou 510642, China

    1 shared publication
  • Jian-Hua Liu

    State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China

    1 shared publication
  • Phillip J. Bergen

    Infection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia

    1 shared publication
  • Wan-Yun He

    State Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Zoonosis of Ministry of Agricultural and Rural Affairs, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China

    1 shared publication
  • Xian-Feng Peng

    Guangzhou Insighter Biotechnology Co., Ltd., Guangzhou 510642, China

    1 shared publication
  • Yi-Yun Liu

    State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China

    1 shared publication

Latest Publications

  • Open Access

    Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales

    by Yi-Yun Liu, Zong-Hua Qin, Hui-Ying Yue, Phillip J. Bergen, Li-Min Deng, Wan-Yun He, Zhen-Ling Zeng, Xian-Feng Peng, Jian-Hua Liu

    Colistin is a last-line antibiotic against Gram-negative pathogens. However, the emergence of colistin resistance has substantially reduced the clinical effectiveness of colistin. In this study, synergy between colistin and capric acid was examined against twenty-one Gram-negative bacterial isolates (four colistin-susceptible and seventeen colistin-resistant). Checkerboard assays showed a synergistic effect against all colistin-resistant strains [(FICI, fractional inhibitory concentration index) = 0.02–0.38] and two colistin-susceptible strains. Time–kill assays confirmed the combination was synergistic. We suggest that the combination of colistin and capric acid is a promising therapeutic strategy against Gram-negative colistin-resistant strains.